These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 32793236)

  • 21. CD137+CD154- Expression As a Regulatory T Cell (Treg)-Specific Activation Signature for Identification and Sorting of Stable Human Tregs from
    Nowak A; Lock D; Bacher P; Hohnstein T; Vogt K; Gottfreund J; Giehr P; Polansky JK; Sawitzki B; Kaiser A; Walter J; Scheffold A
    Front Immunol; 2018; 9():199. PubMed ID: 29467769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory CAR-T cells in autoimmune diseases: Progress and current challenges.
    Riet T; Chmielewski M
    Front Immunol; 2022; 13():934343. PubMed ID: 36032080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Harnessing the inherent power of chimeric antigen receptor (CAR)-expressing regulatory T cells (CAR-Tregs) to treat autoimmune-related disorders.
    Kahmini FR; Shahgaldi S
    Mol Biol Rep; 2022 May; 49(5):4069-4078. PubMed ID: 35534581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD19-targeted CAR regulatory T cells suppress B cell pathology without GvHD.
    Imura Y; Ando M; Kondo T; Ito M; Yoshimura A
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32525846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Driving CARs to BARs: The Winding Road to Specific Regulatory T Cells for Tolerance.
    Scott DW
    Front Immunol; 2021; 12():742719. PubMed ID: 34552599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic testing and specificity mapping of alloantigen-specific chimeric antigen receptors in regulatory T cells.
    Dawson NA; Lamarche C; Hoeppli RE; Bergqvist P; Fung VC; McIver E; Huang Q; Gillies J; Speck M; Orban PC; Bush JW; Mojibian M; Levings MK
    JCI Insight; 2019 Mar; 4(6):. PubMed ID: 30753169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chimeric antigen receptor T
    Eskandari SK; Daccache A; Azzi JR
    Trends Immunol; 2024 Jan; 45(1):48-61. PubMed ID: 38123369
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation.
    Gille I; Claas FHJ; Haasnoot GW; Heemskerk MHM; Heidt S
    Front Immunol; 2022; 13():874157. PubMed ID: 35720402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards antigen-specific Tregs for type 1 diabetes: Construction and functional assessment of pancreatic endocrine marker, HPi2-based chimeric antigen receptor.
    Radichev IA; Yoon J; Scott DW; Griffin K; Savinov AY
    Cell Immunol; 2020 Dec; 358():104224. PubMed ID: 33068914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming barriers to widespread use of CAR-Treg therapy in organ transplant recipients.
    Cremoni M; Massa F; Sicard A
    HLA; 2022 Jun; 99(6):565-572. PubMed ID: 35233971
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors.
    Kosti P; Maher J; Arnold JN
    Front Immunol; 2018; 9():1104. PubMed ID: 29872437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells.
    Dawson NAJ; Rosado-Sánchez I; Novakovsky GE; Fung VCW; Huang Q; McIver E; Sun G; Gillies J; Speck M; Orban PC; Mojibian M; Levings MK
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32817364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chimeric Antigen Receptor T Cell Therapy for Pediatric B-ALL: Narrowing the Gap Between Early and Long-Term Outcomes.
    Schultz L
    Front Immunol; 2020; 11():1985. PubMed ID: 32849662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient mTOR inhibition rescues 4-1BB CAR-Tregs from tonic signal-induced dysfunction.
    Lamarthée B; Marchal A; Charbonnier S; Blein T; Leon J; Martin E; Rabaux L; Vogt K; Titeux M; Delville M; Vinçon H; Six E; Pallet N; Michonneau D; Anglicheau D; Legendre C; Taupin JL; Nemazanyy I; Sawitzki B; Latour S; Cavazzana M; André I; Zuber J
    Nat Commun; 2021 Nov; 12(1):6446. PubMed ID: 34750385
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update.
    Soundara Rajan T; Gugliandolo A; Bramanti P; Mazzon E
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineering CAR-T Cells for Next-Generation Cancer Therapy.
    Hong M; Clubb JD; Chen YY
    Cancer Cell; 2020 Oct; 38(4):473-488. PubMed ID: 32735779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chimeric Antigen Receptor T-Cell Therapy in Lung Cancer: Potential and Challenges.
    Xiao BF; Zhang JT; Zhu YG; Cui XR; Lu ZM; Yu BT; Wu N
    Front Immunol; 2021; 12():782775. PubMed ID: 34790207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of a Chimeric Antigen Receptor Specific for Donor HLA Class I Enhances the Potency of Human Regulatory T Cells in Preventing Human Skin Transplant Rejection.
    Boardman DA; Philippeos C; Fruhwirth GO; Ibrahim MA; Hannen RF; Cooper D; Marelli-Berg FM; Watt FM; Lechler RI; Maher J; Smyth LA; Lombardi G
    Am J Transplant; 2017 Apr; 17(4):931-943. PubMed ID: 28027623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-Specific CAR Targeting to Prevent Antigen Escape.
    Walsh Z; Ross S; Fry TJ
    Curr Hematol Malig Rep; 2019 Oct; 14(5):451-459. PubMed ID: 31332617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chimeric Antigen Receptor Based Therapy as a Potential Approach in Autoimmune Diseases: How Close Are We to the Treatment?
    Sadeqi Nezhad M; Seifalian A; Bagheri N; Yaghoubi S; Karimi MH; Adbollahpour-Alitappeh M
    Front Immunol; 2020; 11():603237. PubMed ID: 33324420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.